O
EXAS

OppenheimerFunds’s Exact Sciences EXAS Stock Holding History

OppenheimerFunds’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$217M Sell
2,500,206
-365,027
-13% -$31.1M 0.27% 95
2018
Q4 		$181M Sell
2,865,233
-1,659,165
-37% -$114M 0.26% 102
2018
Q3 		$357M Sell
4,524,398
-1,045,709
-19% -$68.2M 0.41% 57
2018
Q2 		$333M Sell
5,570,107
-261,240
-4% -$14.1M 0.4% 57
2018
Q1 		$235M Buy
5,831,347
+2,910,506
+100% +$142M 0.29% 93
2017
Q4 		$153M Sell
2,920,841
-114,244
-4% -$6.1M 0.19% 140
2017
Q3 		$143M Buy
3,035,085
+20,938
+0.7% +$843K 0.18% 140
2017
Q2 		$107M Buy
3,014,147
+511,749
+20% +$15.8M 0.13% 181
2017
Q1 		$59.1M Buy
2,502,398
+1,002,398
+67% +$19.9M 0.07% 276
2016
Q4 		$20M Sell
1,500,000
-621,665
-29% -$10M 0.03% 575
2016
Q3 		$39.4M Sell
2,121,665
-1,507,355
-42% -$26.6M 0.05% 392
2016
Q2 		$44.5M Buy
3,629,020
+415,650
+13% +$3.13M 0.06% 343
2016
Q1 		$21.7M Buy
3,213,370
+435,940
+16% +$2.79M 0.03% 537
2015
Q4 		$25.6M Buy
2,777,430
+2,277,430
+455% +$21.2M 0.03% 499
2015
Q3 		$8.99M Hold
500,000
– – 0.01% 741
2015
Q2 		$14.9M Buy
+500,000
New +$12.6M 0.02% 661
2015
Q1 		– Sell
-432,290
Closed -$11.9M – 913
2014
Q4 		$11.9M Sell
432,290
-70,140
-14% -$1.71M 0.01% 726
2014
Q3 		$9.74M Buy
+502,430
New +$9.21M 0.01% 742

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

OppenheimerFunds's EXAS Position: Q1 2019 in Review

OppenheimerFunds reduced its Exact Sciences (EXAS) stake by 13% in Q1 2019, selling an estimated $31.1M and leaving 2,500,206 shares worth $217M. The position accounts for 0.27% of the portfolio, ranked #95.

OppenheimerFunds first reported a position in EXAS in Q3 2014 and has held it in 18 quarters since. The position peaked at $357M in Q3 2018. 424 funds tracked by Wall St. Rank hold EXAS as of Q1 2019.

  • OppenheimerFunds held 2,500,206 shares of Exact Sciences worth $217M as of Q1 2019.
  • OppenheimerFunds sold 365,027 Exact Sciences shares in Q1 2019, an estimated $31.1M.
  • Exact Sciences made up 0.27% of OppenheimerFunds's portfolio in Q1 2019, its #95 holding.
  • OppenheimerFunds first reported a position in Exact Sciences in Q3 2014 and has held it in 18 quarters since.
  • OppenheimerFunds's Exact Sciences position peaked at $357M in Q3 2018.
  • 424 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.